Thyroseq Testing
ID: 36C24925Q0032Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF249-NETWORK CONTRACT OFFICE 9 (36C249)MURFREESBORO, TN, 37129, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/fd2bef7219b74736a9d33057d67c4a3c/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking to award a sole source purchase order for Thyroseq testing services to Cytopath Biopsy Lab, Inc. This specialized testing, utilizing the proprietary ThyroSeq v3 genomic classifier, is designed to assess cancer risk in veteran patients, ensuring high-quality diagnostic capabilities. The contract is estimated to span from October 2024 to September 2029, with costs determined to be fair and reasonable based on historical pricing and market research. Interested parties may submit capability statements by September 30, 2024, at 11:00 AM EST, although the government reserves the right to decide on competitive bidding based on the responses received.

    Point(s) of Contact
    No information provided.
    Files
    Title
    Posted
    P03 FAR 13.5 Sole Source Justification - Over SAT Testing R2.pdf
    The document outlines a Request for Sole Source Justification for acquiring Thyroseq Testing services at the Department of Veterans Affairs, specifically for the Pathology and Laboratory department of the Lt. Col. Luke Weathers, Jr. VA Medical Center in Memphis, TN. The testing, conducted using the proprietary ThyroSeq v3 genomic classifier, assesses cancer risk for veteran patients. The estimated contract spans from October 2024 to September 2029, with costs deemed fair and reasonable based on historical pricing and market research. Due to the proprietary nature of the testing technology, competition is restricted to Cytopath Biopsy Lab, Inc. (CBLPath), which is the sole provider able to meet the requirements. Efforts to source other potential vendors proved unsuccessful. The justification document confirms compliance with federal acquisition regulations (FAR 13.5), supporting the decision to utilize sole-source procurement, aimed at ensuring optimal patient care through advanced diagnostic capabilities.
    S02 36C24925Q0032.pdf
    The Department of Veterans Affairs (VA), through Network Contracting Office 09, intends to award a sole source purchase order for Thyroseq testing services to Cytopath Biopsy Lab, Inc. This specialized service, aimed at assessing cancer risk in veteran patients, involves the use of the proprietary ThyroSeq v3 genomic classifier. The procurement is classified under NAICS code 621511, reflecting a size standard of $41.5 million. The announcement serves as a notice rather than a request for competitive quotes; however, interested parties may submit their capability statements by September 30, 2024, at 11:00 AM EST. Responses will be reviewed, but the government retains discretion in deciding whether to proceed with competitive bidding based on the responses received. The notice includes guidelines for submissions, cautioning against including any proprietary or sensitive information. This initiative underscores the VA's commitment to providing high-quality cancer assessment services for veterans using specialized testing methods.
    Lifecycle
    Title
    Type
    Thyroseq Testing
    Currently viewing
    Special Notice
    Similar Opportunities
    Q301--VISN 04 Reference Laboratory Testing Services (9 Facilites)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Reference Laboratory Testing Services across nine facilities within the Veterans Integrated Service Network (VISN) 04. The procurement aims to establish a Fixed-Priced Indefinite Delivery Indefinite Quantity (IDIQ) contract, valued at approximately $41.5 million, to enhance laboratory testing capabilities for veterans from June 1, 2024, to May 31, 2029. This initiative is crucial for ensuring timely and accurate diagnostic services, which are essential for the health management of veterans. Interested parties must submit their proposals by April 25, 2024, and direct any inquiries to Amanda Saunders at amanda.saunders@va.gov or (412) 822-3731.
    6550--Covid Testing - Base 2
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 17, intends to award a sole-source, Firm-Fixed Price contract to Cepheid for the procurement of COVID-19 testing supplies, specifically the FDA-approved Xpress COV-2/Flu/RSV Plus and Xpress COVID Plus kits. The contract requires the vendor to provide educational materials related to the testing supplies at no additional cost and to ensure that all supplies meet the necessary regulatory standards, including those set by CLIA, FDA, and CAP. This procurement is critical for the North Texas VA Health Care System to maintain effective testing capabilities, and potential vendors are invited to submit capability statements within seven days of this notice; otherwise, the contract will be awarded to Cepheid without further notice. Interested parties can contact Contract Specialist Joe Miller at joseph.miller20@va.gov or by phone at 210-324-7547 for additional information.
    Q301--Anatomic Pathology (Multi-Station) RFQ 36C24424Q0892 replaces RFQ 36C24423Q1176 (Corrective Action) Tiered Soliciation
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Anatomic Pathology services through solicitation RFQ 36C24424Q0892, which replaces a previous solicitation due to corrective action. The contract aims to provide comprehensive pathology testing services for the Wilkes Barre and Philadelphia VA Medical Centers, with a performance period from September 1, 2024, to August 31, 2028. This procurement is particularly significant as it is set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB), reflecting the VA's commitment to supporting veteran-owned enterprises. Interested contractors must submit their offers by October 11, 2024, at 10:00 AM EDT, and inquiries should be directed to Contracting Officer Amanda Saunders at amanda.saunders@va.gov.
    6640--FY25: Prostate Cancer AI Test
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting market research to identify potential sources for a cost-per-test artificial intelligence (AI) solution for prostate cancer evaluation, specifically in accordance with the National Comprehensive Cancer Network (NCCN) clinical guidelines. The procurement aims to find qualified Service Disabled Veteran-Owned Small Businesses (SDVOSBs), Veteran Owned Small Businesses (VOSBs), and Small Businesses capable of delivering testing results within a turnaround time not exceeding 72 hours. This AI test is crucial for patients with localized prostate cancer, as it aids in predicting therapeutic benefits and informs treatment decisions. Interested parties must submit expressions of interest, including company profiles and qualifications, to Mr. Elder Vazquez-Melendez at elder.vazquez-melendez@va.gov by October 3, 2024, at 10:00 am local time.
    Q301--Laboratory Services Sources Sought Non-invasive Post-transplant assay testing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, is seeking information from potential vendors for non-invasive post-transplant assay testing services, including tests for heart and kidney transplants. The Request for Information (RFI) aims to identify sources that can provide assays such as AlloSure Heart, AlloSure Kidney, and AlloMap Heart, which are critical for monitoring transplant patients' health. Interested vendors are encouraged to submit detailed responses regarding their manufacturing capabilities, business size, compliance with regulations, and estimated pricing by October 15, 2024. For further inquiries, vendors can contact Contract Specialist Andrew Misfeldt at andrew.misfeldt@va.gov.
    H146-- Lab Testing Services
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a sole-source contract to AmeriWater LLC for lab testing services, specifically focusing on contaminant, endotoxin, and microbial/bacterial testing, which are critical to the VA's operational requirements. This contract will span one base year with four option years, running from November 1, 2024, to October 31, 2029, and is being procured under the authority of 41 U.S.C. 253(c)(1) and FAR 6.302-1, designating AmeriWater LLC as the only responsible source due to the specialized nature of the services required. Interested parties are invited to submit a capabilities statement by October 3, 2024, at 8:00 AM CST to the VA's Contract Specialist, Marcus Sidney, via email at marcus.sidney@va.gov, with the understanding that registration with the System for Award Management (SAM) is mandatory for eligibility in government contracts.
    J065--WASHINGTON DC | INTENT TO SOLE SOURCE | SUN NUCLEAR SUPPORT SERVICES ONE BASE YEAR PLUS FOUR OPTION YEARS | 11/01/2024 TO 10/31/2025 UCD 10/31/2029
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) in Washington, DC, intends to award a sole-source contract for support services related to Sun Nuclear equipment utilized in the Radiation Oncology department. This contract will cover one base year from November 1, 2024, to October 31, 2025, with four additional one-year options extending through October 31, 2029, and will include comprehensive maintenance services such as preventive and corrective maintenance, requiring all parts and services to be OEM certified. The importance of this procurement lies in ensuring the operational integrity and safety of medical equipment critical for patient care, while also emphasizing compliance with safety regulations and the protection of patient health information. Interested vendors, particularly service-disabled veteran-owned and small businesses, are encouraged to submit their qualifications to the primary contact, Amy Walter, at Amy.Walter1@va.gov, as this notice serves as market research and is not a solicitation for bids.
    6515--36C242-24-AP-4875 | 528-25-1-4085-0001 BkSpecto Ultrasound
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract for the procurement of a BK Specto Ultrasound Unit and associated probes for urologic procedures, effective October 1, 2024. This procurement is necessitated by the discontinuation of critical disposable biopsy guides for existing ultrasound probes, which has severely limited the operational capacity of the urology department, leaving them reliant on a single remaining probe. The BK Specto Ultrasound Unit is essential for conducting prostate biopsies and ensuring effective patient care in urology, following the obsolescence of previous equipment. Interested suppliers may submit capability statements to Contract Specialist Barry Sawyer at Barry.Sawyer@va.gov by September 30, 2024, at 4:00 PM (ET), as this notice is not a request for quotes.
    Sole Source Posting - Research Triangle Institute International
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a qualified organization to provide semi-annual inspections and quarterly proficiency testing for the Minneapolis VA Healthcare System Forensic Toxicology Laboratory. The objective of this procurement is to ensure compliance with the Substance Abuse and Mental Health Administration (SAMHSA) and the Department of Health and Human Services National Laboratory Certification Program, which is essential for the laboratory to continue performing workplace drug testing for Veterans Administration Medical Centers across the United States. The contract is set to begin on October 1, 2024, and will span five annual ordering periods, with the primary contact for this opportunity being Joey Bloomer, who can be reached at joseph.bloomer@va.gov or by phone at 515-699-5549.
    6550--MPLS - Unrestricted Solicitation - Supply - Microbiology Reagents
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of microbiology reagents and diagnostic test kits through an unrestricted solicitation for the Minneapolis Veterans Affairs Medical Center. The contract, identified as 36C26325Q0017, aims to supply various in-vitro diagnostic substances essential for enhancing medical capabilities and patient care, with a focus on critical health services. This initiative is particularly important as it ensures the availability of necessary diagnostic materials while promoting competition among small businesses, including those owned by women and veterans. The contract is set to commence on October 1, 2024, and will run through September 30, 2025, with options for extension until 2028. Interested parties can reach out to Contracting Officer Joseph A. Bloomer at Joseph.Bloomer@va.gov for further details.